Remember one thing when reading analysts reports on
CHTP - Anyone who buys stock in the biotec arena is
basically a gambler and that includes myself. I
firmly believe analysts are also playing cards in
this space. Reports on company's help their friends
and themselves according to which direction they are
looking to move the pps. If you study the facts on
Drox. this drug will be eventually approved. To me,
dizziness equals falls and Drox. was significantly
effective for this indication. The older population
had trouble measuring any improvement in dizziness
which is not uncommon. Falls either happen or they
don't and are not reliant on a persons quess. FDA
will approve changes to end point and we move
forward along with pps. Good luck to all. Regards.